REQUEST A DEMO
Total
USD $0.00
Search more companies

Lonza Biologics Tuas Pte. Ltd. (Singapore)

Main Activities: Biological Product (except Diagnostic) Manufacturing
Full name: Lonza Biologics Tuas Pte. Ltd. Profile Updated: July 18, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Lonza Biologics Tuas Pte. Ltd. is an enterprise located in Singapore, with the main office in Singapore. The company operates in the Biological Product (except Diagnostic) Manufacturing sector. The company was established on October 04, 2006. It currently has a total number of 100 (estimated) employees. There was a net sales revenue increase of 23.48% reported in Lonza Biologics Tuas Pte. Ltd.’s latest financial highlights for 2024. There was a total growth of 23.42% in Lonza Biologics Tuas Pte. Ltd.’s total assets over the same period. The net profit margin of Lonza Biologics Tuas Pte. Ltd. decreased by 4.71% in 2024.

Headquarters
35 Tuas South Avenue 6, Singapore
Singapore; Singapore; Postal Code: 637377

Contact Details: Purchase the Lonza Biologics Tuas Pte. Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Lonza Biologics Tuas Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Lonza Biologics Tuas Pte. Ltd. report to view the information.
Incorporation Date:
October 04, 2006
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
83.33%
Company Performance
Financial values in the chart are available after Lonza Biologics Tuas Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
23.48%
Total Operating Revenue
23.48%
Net Profit/Loss for the Period
-0.49%
Total Assets
23.42%
Total Equity
33.77%
Net Profit Margin
-4.71%
Return on Equity (ROE)
-6.78%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?